Acinetobacter baumannii isolate AP was recovered from a bronchial lavage of a patient hospitalized in Paris, France. A. baumannii AP was resistant to all ␤-lactams, including carbapenems, and produced the extendedspectrum ␤-lactamase (ESBL) GES-14, which differs from GES-1 by two substitutions, Gly170Ser and Gly243Ala. Cloning of the bla GES-14 gene followed by its expression in Escherichia coli showed that GES-14 compromised significantly the efficacy of all ␤-lactams, including cephalosporins, aztreonam, and carbapenems. The carbapenemase activity of purified GES-14 was confirmed by kinetic studies. The bla GES-14 gene was located into a class 1 integron structure and located onto a ca. 95-kb self-transferable plasmid. This study identified a very broad-spectrum ␤-lactamase in A. baumannii.
Acinetobacter baumannii is an opportunistic pathogen that is an important source of nosocomial infections, such as pneumonia, septicemia, urinary tract infections, and wound infections (3) . Treatment of infections due to this microorganism is becoming a serious clinical concern since A. baumannii is frequently resistant to multiple antibiotics (17, 18) . One of the main mechanisms of resistance to ␤-lactam molecules in A. baumannii is the production of ␤-lactamases. Resistance to carbapenems is mostly related to production of metallo-␤-lactamases or carbapenem-hydrolyzing oxacillinases (26) , whereas resistance to broad-spectrum cephalosporins usually results from overexpression of the natural AmpC-type enzyme (4) or in sporadic cases from acquisition of extended-spectrum ␤-lactamases (ESBLs) in A. baumannii. Those ESBLs may correspond to TEM or SHV derivatives but correspond mostly to Ambler class A ␤-lactamases of the VEB or PER types (15) . ESBLs of the GES type are reported increasingly for Gramnegative rods, including Pseudomonas aeruginosa, Enterobacter cloacae, and Klebsiella pneumoniae (8, 20, 22, 25) . GES-1 possesses a hydrolysis profile similar to that of other clavulanateinhibited Ambler class A ESBLs (1), including activity against penicillins and broad-spectrum cephalosporins, with higher activity against ceftazidime than against cefotaxime. Also, GES-1 spares cephamycins and carbapenems and is inhibited by clavulanate, tazobactam, and imipenem (22) . However, unlike most ESBLs, GES-1 does not hydrolyze monobactams. GES-2, which differs from GES-1 by a single Gly170Asn substitution located inside the ⍀-loop of the catalytic site, hydrolyzes additionally carbapenems, but at a low level (23) . A Gly170Ser change was identified in GES-4, GES-5, and GES-6 and resulted in carbapenem and cephamycin hydrolysis. GES-9, which differs from GES-1 by a Gly243Ser change, does not hydrolyze carbapenems but was shown to possess an activity against monobactams (15) . GES-11, differing from GES-1 by two amino acid substitutions, including the Gly243Ala change, possesses increased activity against aztreonam and has recently been identified in A. baumannii (12) .
Our study was initiated by the isolation of a carbapenemresistant and ESBL-producing A. baumannii isolate in Paris, France, that was the source of a nosocomial dissemination.
MATERIALS AND METHODS
Bacterial strains and plasmids. Identification of A. baumannii AP was performed by using the API 32GN system (bioMérieux, Marcy l'Etoile, France) and was confirmed by 16S rRNA gene sequencing as described previously (6) . The Escherichia coli TOP10 reference strain was used as a host for cloning. The kanamycin-resistant plasmid pTOPO (Invitrogen, Cergy-Pontoise, France) was used as a cloning vector in E. coli. A. baumannii BM4547 rifampin-resistant and E. coli TOP10 reference strains were also used as recipients for mating-out and electroporation assays.
Antimicrobial agents and MIC determinations. The antimicrobial agents and their sources have been described elsewhere (19) . Susceptibility testing was performed by disk diffusion assay (Sanofi-Diagnostic Pasteur, Marnes-la-Coquette, France) and interpreted as described previously (5) . The MICs were determined by Etest (AB Biodisk, Solna, Sweden) on Mueller-Hinton agar plates at 37°C (21) . Production of an ESBL was searched by using synergy tests with disks containing ceftazidime and ticarcillin-clavulanic acid and by using cloxacillin-containing Mueller-Hinton agar plates as described previously (21) .
PCR and cloning experiments. Whole-cell DNA of A. baumannii isolate AP was extracted as described previously (19) . This DNA was used as a template under standard PCR conditions (29) with a series of primers designed for the detection of class A ␤-lactamase genes: bla TEM , bla SHV , bla PER-1 , bla VEB-1 , bla GES-1 , and bla CTX-M (20, 21, 23, 24) . Class B and D carbapenemase genes were screened using primers specific for the bla IMP , bla VIM , bla SIM , bla , bla , bla , and bla OXA-143 genes (23, 9) . Since several ␤-lactamase genes are part of gene cassettes which are located in class 1 integrons, primers located in the 5Ј-CS (primer INT2F, 5Ј-TCTCGGGTAACATCAAGG-3Ј) and 3Ј-CS (primer 3ЈCS, 5Ј-AAGCAGACTTGACCTGA-3Ј) regions were used for PCR amplifications as described previously, with an elongation step extended to 10 min (23) . The obtained PCR fragment was purified with a QIAquick column (Qiagen, Courtaboeuf, France) and cloned into the pTOPO vector (Qiagen, Courtaboeuf, France). Recombinant plasmids were selected onto Trypticase soy (TS) agar plates containing ceftazidime (2 mg/ml) and kanamycin (30 mg/ml). The cloned DNA fragment inserted into one of the recombinant plasmids was sequenced on both strands with an Applied Biosystems sequencer (ABI 377). The nucleotide and deduced amino acid sequences were analyzed and compared to sequences available over the Internet at the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov/BLAST/).
Analysis of the comM gene, known as a target of AbaR resistance islands in A. baumannii, was performed by amplifying that hot spot integration site with primers comM-3ЈF (5Ј-GATTACCTCGATAAGAGAGTG-3Ј) and comM-5ЈR (5Ј-TTACACGCGCCTCTCATTGAG-3Ј) as previously described (7) .
Plasmid content, hybridizations, and mating-out assays. The plasmid DNA of A. baumannii AP was extracted by using the Kieser method (11) . E. coli NCTC50192, harboring four plasmids of 154, 66, 48, and 7 kb, was used as a plasmid size marker. Plasmid DNAs were analyzed by agarose gel electrophoresis as described previously (21) . Restricted plasmid DNA fragments were transferred to a nylon membrane (Hybond Nϩ; GE Healthcare, Orsay, France) by the Southern technique (29) . The DNAs were then UV cross-linked (Stratalinker; Stratagene). An 860-bp PCR-generated probe (primers GES-A and GES-B) was used for hybridization of genes encoding GES-type ␤-lactamases.
Direct transfer of the ceftazidime resistance marker into A. baumannii BM4547 was attempted by liquid mating-out assays at 37°C and by electroporation of a plasmid DNA suspension extracted from A. baumannii AP into A. baumannii BM4547 overproducing the efflux system AdeABC and into E. coli TOP10. Selection was performed on agar plates supplemented with ceftazidime (2 g/ml).
␤-Lactamase purification. Cultures of E. coli TOP10 harboring recombinant plasmid pTOPO-GES-14 were grown overnight at 37°C in 4 liters of TS broth containing amoxicillin (50 g/ml) and kanamycin (30 g/ml). ␤-Lactamase GES-14 was purified by ion-exchange chromatography. Briefly, the bacterial suspension was pelleted, resuspended in 40 ml of 100 mM sodium phosphate buffer (pH 7.0), sonicated, cleared by ultracentrifugation, and treated with DNase. The extract was then dialyzed against 20 mM bis-Tris {[bis(2-hydroxyethyl-imino]tris(hydroxymethyl)methane}(pH 6.5) and loaded onto a preequilibrated Q-Sepharose column with the same buffer. The resulting enzyme extract was recovered in the flowthrough and dialyzed against 20 mM Tris-HCl (pH 7.5) overnight at 4°C. This extract was then loaded onto a preequilibrated (20 mM Tris-HCl [pH 7.5]) Q-Sepharose column, and the proteins were eluted with a linear NaCl gradient (0 to 0.5 M). The ␤-lactamase activity was eluted with NaCl at a concentration of 200 mM in the same Tris-HCl buffer. Finally, fractions containing the highest ␤-lactamase activities were pooled and subsequently dialyzed overnight against 100 mM phosphate buffer (pH 7.0). The ␤-lactamase activity was determined qualitatively using nitrocefin hydrolysis (Oxoid, Dardilly, France). The protein content was measured using the Bio-Rad DC protein assay.
Kinetic studies. Kinetic measurements (k cat and K m ) of purified ␤-lactamase GES-14 were performed as described previously (24) . The 50% inhibitory concentration (IC 50 ) was determined for GES-14 as the concentration of clavulanate and tazobactam that reduced the hydrolysis rate of 100 M benzylpenicillin by 50%, under conditions in which GES-14 was preincubated with various concentrations of inhibitor for 10 min at 30°C, before the substrate was added.
Nucleotide sequence accession number. The nucleotide sequence data reported in this work have been deposited in the GenBank nucleotide database under accession no. HM451497.
RESULTS AND DISCUSSION
Susceptibility testing. A. baumannii AP was isolated from a bronchial sample of a 34-year-old patient hospitalized in an intensive care unit at the Necker-Enfants Malades University Hospital (Paris, France) in January 2010. A. baumannii AP was resistant to penicillins, ␤-lactamase inhibitor/penicillin combinations, broad-spectrum cephalosporins, aztreonam, and carbapenems (Table 1) . Synergy between ceftazidime and clavulanic acid observed with media supplemented with cloxacillin suggested the production of an ESBL. In addition, A. baumannii AP was resistant to aminoglycosides, fluoroquinolones, sulfonamides, and tetracycline and showed susceptibility only to colistin and rifampin.
Identification of naturally occurring ␤-lactamase genes. A. baumannii AP harbored the naturally occurring bla OXA-91 gene, also known as bla OXA-Ab-24 (27) . No ISAba1 element preceded that bla OXA-Ab-24 gene or the intrinsic bla ampC gene in A. baumannii AP, likely indicating that both genes were not overexpressed. In addition, PCR and sequencing showed that the comM gene was intact in A. baumannii AP, thus ruling out the presence of an AbaR resistance island, at least at that location. Cloning and sequencing of the ESBL gene. Using whole-cell DNA of A. baumannii AP as a template, preliminary PCR detection of class B and class D carbapenem-hydrolyzing ␤-lactamase genes failed (data not shown), but a PCR amplification was obtained with bla GES-1 -specific primers. Since bla GES-like genes are known to be integron encoded, consensus primers 5Ј-CS and 3Ј-CS for class 1 integrons were used, and PCR amplification gave an 8-kb DNA fragment that was subsequently cloned into vector pTOPO and expressed in E. coli TOP10. The resulting recombinant strain E. coli TOP10(pTOPO-GES-14) displayed an ESBL phenotype with high-level resistance to ceftazidime and reduced susceptibility to aztreonam, cefoxitin, and carbapenems (Table 1 ). In addition, it was resistant to chloramphenicol, trimethoprim, kanamycin, tobramycin, streptomycin, and spectinomycin but remained susceptible to sulfonamides. Sequence analysis of the cloned DNA fragment revealed an 864-bp-long open reading frame encoding a 287-amino-acid preprotein designed as GES-14, differing by one single substitution from GES-5 (Gly243Ala) and from GES-11 (Gly170Ser) and by two amino acid substitutions (Gly170Ser and Gly243Ala) from GES-1 (Fig. 1) . The Gly170Ser substitution firstly identified in GES-5 is known to confer to that enzyme a higher catalytic efficiency toward carbapenems and cephamycins (2, 30) , although the Gly243Ala substitution firstly identified in GES-9 increases the catalytic activity of that enzyme toward aztreonam (25) . Therefore, the susceptibility pattern observed for E. coli TOP10(pTOPO-GES-14) that showed reduced susceptibility to cephamycins, monobactams, and carbapenems in addition to oxyimino-cephalosporins was similar to those previously observed. This suggested that GES-14 might combine both GES-5 and GES-9 hydrolysis spectra, thus defining that enzyme as the first ␤-lactamase hydrolyzing significantly all ␤-lactams.
Biochemical properties of GES-14. The pI value of GES-14 was determined to be 5.8. After a purification process, the purity of the enzyme was estimated to be 90% according to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (data not shown). Kinetic parameters of GES-14 confirmed its broad-spectrum activity against all ␤-lactams, including, in particular, oxyimino-cephalosporins, monobactams, and carbapenems ( Table 2 ). The hydrolysis rates of GES-14 for penicillins
FIG. 1. Alignment of the amino acid sequences of ␤-lactamases GES-1, GES-2, GES-5, GES-6, GES-7 (IBC-1)
, GES-9, GES-11, GES-13, and GES-14. Boldface amino acids are conserved residues among Ambler class A ␤-lactamases. The amino acids of the omega loop are underlined. were similar to those of GES-1 and GES-2 (except for piperacillin) but were lower than those observed for GES-9, which possesses a serine at position 243 (25) ( Fig. 1 ; Table 2 ). The hydrolysis rates of GES-14 for cephalosporins were similar to those found for GES-1 and GES-2. However, the very high maximum rate of metabolism (V max ) value obtained for that substrate confirmed that it was efficiently hydrolyzed by GES-14 ( Table 2) . GES-14 also efficiently hydrolyzed imipenem, with a k cat /K m value 4-fold higher than that of GES-2.
In addition, GES-14 hydrolyzed meropenem and ertapenem at rates similar to those for imipenem. This is in accordance with previous findings obtained for demonstrating that the serine residue at position 170 conferred significant carbapenemase activity to GES derivatives. The hydrolysis of aztreonam was also significant despite a low affinity (K m Ͼ 5,000 M) for this substrate. GES-14 exhibited relatively low catalytic efficiency for some substrates compared to many other class A ␤-lactamases, such as TEM or SHV derivatives, but conferred high resistance to ␤-lactams. This discrepancy might be related to a high level of expression of the bla GES-14 gene in A. baumannii AP, in accordance with the identification of a strong promoter configuration (see below). Inhibition studies, carried out by measuring the IC 50 s, showed that the catalytic activities of GES-14 and GES-2 were similarly inhibited by clavulanic acid (Table 3) .
Genetic support of bla GES-14 gene and transfer of ␤-lactam resistance. Plasmid DNA analysis showed that A. baumannii AP harbored a 95-kb plasmid (data not shown). Mating-out assays gave the A. baumannii BM4547 strain harboring natural plasmid pAP, which harbored the bla GES-14 gene and showed an ESBL phenotype. It was also resistant to carbapenems, indicating that acquisition of ESBL GES-14 together with efflux overproduction (a property of A. baumannii BM4547) led to resistance to carbapenems. In addition, that transconjugant had acquired resistance to chloramphenicol, tetracycline, and aminoglycosides. Attempts to transfer the bla GES-14 -carrying natural plasmid pAP into the E. coli TOP10 recipient strain by conjugation and electroporation failed. This may indicate that plasmid pAP possesses a host replication range that excludes E. coli. Southern hybridization performed with a bla GES-14 -specific probe confirmed that this gene was located on a 95-kb plasmid in A. baumannii AP (data not shown).
Genetic environment of the bla GES-14 gene. Sequencing of the entire insert of recombinant plasmid pTOPO-GES-14 revealed that bla GES-14 was present in the form of a gene cassette, preceded by an intI1 integrase gene of a class 1 integron that was named In125. Detailed analysis of the sequences located upstream of bla revealed that a 238-bp fragment was missing compared to the In52 integron carrying the bla GES-1 gene as the first cassette (22) (see Fig. 3 ). Consequently, the integrase gene upstream of the bla GES-14 gene was truncated in its 5Ј extremity, resulting in the lack of the first 28 N-terminal amino acids of the corresponding protein. This suggested that this integrase was not functional here. In addition, the entire attI1 recombination site was absent, together with the first 14 bp of the bla GES-14 gene cassette (Fig. 2) . Noteworthy, in silico analysis showed that the same deletions had occurred upstream of the bla GES-11 gene in A. baumannii BM4674 (Fig. 2) (14) . Overall, the In125 integron appears to be a stable genetic structure that cannot acquire or lose its cassette content. The attI1 deletion might be the consequence of a recombination event that had been mediated by the integrase itself. Indeed, it has been demonstrated already that the class 1 integron integrase may induce some nonspecific recombination events in the attI1 region, with a preferential G(T/A)T target site that fits with the sequence where the deletion has occurred in In125 (Fig. 3) (28) .
As a consequence of the deletion of the attI sequence, no P 2 promoter was identified for gene cassette expression in In125. However, the P c promoter was still present and, as a consequence of that deletion, was located very close to the bla on September 22, 2017 by guest http://aac.asm.org/ start codon (the codon being only 31 bp from the Ϫ10 promoter sequence of P c ). Analysis of the Ϫ35 and Ϫ10 P c promoter sequences of the In125 P c promoter (being Ϫ35 TTGACA and Ϫ10 TGGACA) showed that it corresponded to the so-called pPcH2 hybrid promoter possessing relative strength (10, 12, 16) . All those features, e.g., a strong promoter configuration that is located at a short distance from the transcription initiation site, suggest that the bla GES-14 gene is expressed here at a high level. Since the integrase gene located immediately upstream of bla GES-14 was truncated and since the usual attI1 was missing here, it is likely that this integron is defective. Downstream of the bla GES-14 gene, the aacA4 gene cassette encoding the AAC(6Ј)-Ib aminoglycoside acetyltransferase was identified. It was followed by the dfrA7 gene cassette encoding resistance to trimethoprim and then by the qacE⌬1 gene cassette specific for the 3Ј extremity of class 1 integrons.
On the left-hand extremity of the In125 sequence, part of the tnpM gene encoding the modulation transposase protein that is itself part of the Tn21 transposon module vehiculating class 1 integrons was identified (Fig. 2) . The tnpM gene was truncated in its 3Ј extremity. Then, the two streptomycin resistance genes strA and strB previously identified in Tn5393-like transposons were identified (13) . Interestingly, downstream of that structure, another class 1 integron containing three gene cassettes was identified. The first and third cassettes corresponded, respectively, to aadB and aadA2, both encoding resistance to streptomycin and spectinomycin. The second cassette encoded a CmlA5-like protein (98% amino acid identity) conferring resistance to chloramphenicol (Fig. 2) . At the 3Ј extremity of that integron, neither the qacE⌬1 nor sul1 gene was found, since the genes have been replaced by the insertion of the strA and strB genes.
Overall, and likely as a result of homologous recombination, a large structure that corresponds to a fusion of two class 1 integrons has been identified and contains a total of eight resistance genes.
Conclusion. This study characterized a novel carbapenemhydrolyzing GES-type ␤-lactamase from A. baumannii. The hydrolysis spectrum of GES-14 includes cephamycins and carbapenems and therefore corresponds to that of the first GEStype enzyme, and its substrate profile includes all ␤-lactams, as a consequence of two amino acid substitutions.
To the best of our knowledge, GES-14 is the first identified ␤-lactamase hydrolyzing significantly all ␤-lactams, since both the Ambler class A KPC-2 and the class B carbapenemases do not hydrolyze cephamycins and monobactams, respectively. The bla GES-14 gene was located on a plasmid, which underlines its diffusion potency, at least among Acinetobacter spp. That plasmid harbored a large array of resistance genes encoding resistance to several antibiotic families and therefore represents one of the few examples of plasmid-mediated multidrug resistance in A. baumannii, since recent studies tend to associate multidrug resistance mostly to the chromosomally located AbaR resistance islands. FIG. 3 . Comparative structures of the sequences located upstream of the bla GES-14 and bla GES-1 genes. The 238-bp nucleotide sequence that is deleted in In125 containing bla GES-14 (A) but present in In52 containing bla GES-1 (B) is represented. The sequences of the promoters are underlined, and the attI1 recombination site is italicized. The Ϫ35 and Ϫ10 sequences of the P c and P 2 promoters are underlined, and the start codons of the bla GES genes are in bold. The core site sequence of the bla GES-1 gene cassette is boxed. 
